financetom
Business
financetom
/
Business
/
Pentagon set to award US Air Force's next-generation fighter jet contract, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pentagon set to award US Air Force's next-generation fighter jet contract, sources say
Mar 20, 2025 5:24 PM

*

Boeing ( BA ) and Lockheed vying for F-22 replacement contract

*

New sixth-generation fighter to battle alongside drones

*

Winner could eventually receive hundreds of billions of

dollars

in orders

(Adds context, and details on the program and its stakes)

By Mike Stone

WASHINGTON, March 20 (Reuters) - The Pentagon is set to

announce its decision on a next-generation fighter jet contract

initially worth more than $20 billion as soon as Friday, despite

earlier concerns about budget constraints and shifting

priorities, sources briefed on the plan said.

The Next Generation Air Dominance (NGAD) program will

replace Lockheed Martin's ( LMT ) F-22 Raptor with a fighter

built to battle alongside drones.

Lockheed and Boeing ( BA ) are competing head to head for

the winner-take-all engineering and manufacturing development

phase contract worth more than $20 billion.

An Air Force spokesperson and Boeing ( BA ) and Lockheed

representatives did not immediately respond to requests for

comment.

The winner of the high-stakes contest will receive hundreds

of billions of dollars in orders over the contract's lifetime,

underpinning their businesses for decades.

NGAD was conceived as a "family of systems" centered

around a sixth-generation fighter jet that aims to provide the

United States with advanced air dominance capabilities to

counter near-peer adversaries like China and Russia.

Under President Donald Trump's administration, which took

office in January, the program has moved forward after a period

of uncertainty that cast doubt on the future of the

next-generation fighter jet.

Last year, the program faced potential delays or scaling

back due to budget pressures and cost overruns in other Air

Force programs. There were also discussions about reconsidering

fundamental design elements or shifting resources to unmanned

drone programs.

The anticipated announcement signals designs that were

finalized last year will be chosen for NGAD.

Boeing ( BA ) has suffered headwinds for both its commercial and

defense businesses. A win would be a shot in the arm for its St.

Louis, Missouri, fighter jet production businesses, while a loss

would add to Boeing's ( BA ) woes.

Lockheed was recently eliminated from the competition to

build the Navy's next-generation carrier-based stealth fighter.

If it loses the NGAD contract, it will likely double down on its

F-35 fighter jet program and international sales of its F-16

jets.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Electric Metals (USA) Files Technical Report on Upgraded Resource Estimate at Emily Project in Minnesota
Electric Metals (USA) Files Technical Report on Upgraded Resource Estimate at Emily Project in Minnesota
May 27, 2024
09:28 AM EDT, 05/27/2024 (MT Newswires) -- Electric Metals (USA) ( EMUSF ) filed Monday an NI 43-101 technical report on the upgraded resource estimate for the Emily manganese project in Minnesota, confirming the highest grade manganese resource in North America. A statement noted, at a 10% cutoff grade, indicated resources increased 20.9% to 6.2 million tonnes grading 19.27% manganese....
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases
May 27, 2024
Coya Therapeutics Inc ( COYA ) is a clinical-stage biotechnology company developing treatments focused on regulatory T cells (Tregs) to target systemic inflammation and neuroinflammation.  Since its IPO in December 2022, Coya shares have surged around 70%, significantly outperforming the Invesco S&P SmallCap Health Care ETF ( PSCH ) . Howard Berman, Chairman and CEO of Coya Therapeutics ( COYA...
Brazil's Gol says bankruptcy exit to involve $1.5 billion capital injection
Brazil's Gol says bankruptcy exit to involve $1.5 billion capital injection
May 27, 2024
SAO PAULO (Reuters) - Brazilian airline Gol expects its exit of Chapter 11 bankruptcy proceedings to involve a $1.5 billion capital injection through the issuance of new shares and the refinancing of $2 billion in debt, it said in a securities filing on Monday. Gol, one of Brazil's largest carriers, filed for bankruptcy protection in the United States earlier this...
Lancia to return to rallying with Ypsilon model - CEO
Lancia to return to rallying with Ypsilon model - CEO
May 27, 2024
MILAN, May 27 (Reuters) - Lancia CEO Luca Napolitano said on Monday the Italian brand, part of the Stellantis ( STLA ) automotive group, will go back to rally races with its Ypsilon model. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved